Tower Research Capital LLC (Trc) Lantern Pharma Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,515 shares of LTRN stock, worth $5,363. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,515
Previous 1,339
13.14%
Holding current value
$5,363
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding LTRN
# of Institutions
34Shares Held
1.29MCall Options Held
39.8KPut Options Held
6.1K-
Vanguard Group Inc Valley Forge, PA364KShares$1.29 Million0.0% of portfolio
-
Cm Management, LLC185KShares$654,9000.57% of portfolio
-
New Edge Advisors, LLC New Orleans, LA137KShares$486,1760.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$309,5190.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny84KShares$297,3600.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $38.3M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...